x

Webinar: The potential of iPSC-derived endothelial cells ​​​​​​​for efficacy and safety screening

Webinar: The potential of iPSC-derived endothelial cells for efficacy and safety screening In this webinar, we will present the potential of Ncardia's iPSC-derived endothelial cell models. We have developed a controlled process for large-scale manufacturing of iPSC-derived endothelial cells and scalable assays for drug efficacy and safety screenings, with the aim of bringing better medicines to patients faster

Join us for the live session with Q&A next Thursday May 26th at 3PM. Jessica Koepke, scientist at Ncardia, will be happy to answer your questions.

Register now